Pharma Journalist -

Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca. The partnership is based on an expanded deal this year in May 2021 which…
Read More...

Novo Nordisk announced plans to invest more than 17 bn Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its…
Read More...

Pfizer Inc. announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for the…
Read More...

Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies…
Read More...

SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022.…
Read More...

SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference. SMi Group is delighted to announce the return of the successful 3D Cell Culture…
Read More...

Rapid Dose Therapeutics Corp. a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland…
Read More...

Syndax Pharmaceuticals, Inc. announced that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and that the parties closed the exclusive worldwide collaboration and…
Read More...

Prestige BioPharma Ltd. and Dr. Reddy’s Laboratories Ltd. announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and…
Read More...

AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the…
Read More...